The Series A Preferred Stock Term Sheet: A Founder's Section-by-Section Guide
A term sheet is a two- to four-page summary of the principal economic and control terms of a preferred stock financing. It is almost entirely non-binding — the only clauses that typically survive without a signed definitive agreement are exclusivity ("no-shop"), confidentiality, and expense reimbursement. Everything else is an outline of the deal the lawyers will document later.
Founders often celebrate the moment a term sheet lands. That is fair — a signed term sheet is a real commitment of investor time and social capital. But the term sheet is also where the deal is actually negotiated. Once it is signed, the definitive documents almost always mirror it word for word. Every provision below is worth reading, understanding, and pushing back on before you sign.
This guide walks through a standard Series A preferred stock term sheet, section by section, from the perspective of a first-time founder.
Every clean term sheet opens with three things: the company name and state of incorporation, a statement that the terms summarize a proposed Series A Preferred Stock financing, and an express acknowledgment that no legally binding obligation is created until definitive agreements are signed. The financing is explicitly conditioned on the completion of diligence and documentation satisfactory to the investors.
Read that carefully. It means the investor can walk away for almost any reason during the diligence window. Your job is to keep that window short — 3 to 4 weeks is standard.
Pre-money valuation. The value of the company before the new money goes in.
Investment amount. The total dollars being raised in this round.
Price per share. Pre-money valuation divided by the fully-diluted pre-money share count.
The critical trap is the option pool shuffle. Term sheets almost always require you to expand your unallocated option pool to some target (often 10–15% post-money) before the money goes in. That expansion dilutes only existing shareholders, not the new investors. A "$10M pre" with a 15% pre-money option pool refresh is meaningfully lower than "$10M pre" with a post-money refresh. Always ask whether the option pool is calculated pre- or post-money, and always model both scenarios.
Liquidation preference is what preferred shareholders get paid before common (founders and employees) in any sale, merger, or wind-down. It has three moving parts:
Multiple — 1x is standard. Anything above 1x (2x, 3x) is a red flag outside of distressed deals.
Participation — Non-participating means investors choose either their preference or their pro-rata share of the remaining proceeds. Participating ("double dip") means they get their preference and their pro-rata share. Non-participating is the market standard.
Cap — On a participating preferred, a cap (e.g., 3x) limits how much the investor can take before converting to common.
The founder-friendly ask is 1x non-participating preferred. The founder-hostile version is 2x participating preferred with no cap. Everything in between is negotiable.
If you raise a future round at a lower price per share (a "down round"), anti-dilution protection adjusts the conversion price of the preferred shares to compensate investors for the reduced valuation. Two flavors exist:
Broad-based weighted average — the market standard. Adjusts the conversion price based on both the size of the down round and the size of the company. Modest, formula-driven dilution to common.
Full ratchet — the founder-hostile version. Resets the conversion price all the way down to the new lower price, regardless of round size. Punitive.
Almost every reputable term sheet uses broad-based weighted average. If you see full ratchet, negotiate it out.
Dividends on preferred stock are usually a formality in venture deals — 6–8% non-cumulative dividends "when and if declared by the board." Because they are non-cumulative and rarely declared, they have no real economic effect. Watch for cumulative dividends, which accrue every year whether declared or not and get paid out on top of the liquidation preference at exit. Cumulative dividends are a hidden 6–8% preference multiplier every year — over five years, that is a materially larger check to the investor at exit. Push back.
Redemption rights let investors force the company to buy back their preferred shares after a fixed period (typically 5 years), often at cost plus accrued dividends. In practice they are almost never exercised — a company that could afford to redeem a Series A can usually raise instead. But they exist as a signaling and pressure lever. Standard is either no redemption right or a 5-year right at cost.
Preferred converts to common at any time at the holder's option (standard), and automatically on a qualified IPO (usually defined as a public offering at some minimum price per share and aggregate proceeds — e.g., 3x the original issue price and $50M+ raised) or on a majority vote of the preferred. This is standard and rarely negotiated.
Preferred votes with common on an as-converted basis on most matters. On top of that, protective provisions give the preferred a class-level veto over specific actions — changing the certificate of incorporation, creating a senior class of stock, issuing debt above a threshold, selling the company, changing board size, paying dividends. A tight list is reasonable. A sprawling list that requires preferred approval for hiring, budgets, or ordinary-course contracts is not — that is operational control disguised as protection. Negotiate materiality thresholds ($X of debt, sales above $Y).
Board composition is often more important than valuation. A typical Series A board is three or five seats:
Three-seat board (founder-friendly): 1 founder / CEO seat, 1 investor seat, 1 independent director mutually agreed. Founders retain de facto control because the independent typically defers to the CEO.
Five-seat board: 2 founders, 2 investors, 1 independent. Investor influence grows, but founders still have parity.
Investor-controlled board: any composition where investors + independent > founders + friendly. Avoid at Series A if at all possible.
Board control matters because the board — not the shareholders — hires and fires the CEO, approves budgets, approves acquisitions, and signs off on future financings. Losing the board at Series A means you have effectively given up the company.
Pro-rata rights let investors participate in future rounds up to their ownership percentage, preserving their stake. This is standard and reasonable — grant it to major investors (those above a defined ownership threshold). Two things to watch for: (a) super pro-rata rights (the right to invest more than their pro-rata share) — decline; (b) pro-rata rights that survive after a Series B without a "pay-to-play" provision — negotiate a cap.
Standard for major investors: quarterly unaudited financials, annual audited financials, an annual budget 30 days before year-end, and a monthly summary. These are reasonable and required for the investor's own fund reporting. Push back only on real-time or ad-hoc reporting demands.
Right of First Refusal and Co-Sale (Right of First Refusal / Tag-Along)
If a founder wants to sell shares to a third party, the company (first) and then the investors (second) have the right to buy those shares on the same terms. If they decline, the investors have a "co-sale" right — the right to sell their proportional share of stock alongside the founder in the same transaction. This is designed to prevent founders from cashing out privately while investors are locked in. Standard and hard to negotiate away.
Drag-along says: if a defined majority of investors and the board approve a sale of the company, all shareholders (including common) are contractually required to vote in favor and sign the deal documents. This exists so a small minority of common holders cannot block a legitimate exit. Standard, but negotiate the trigger — it should require both preferred majority and common majority and board approval, not just preferred alone.
Almost every Series A term sheet requires founders to place their stock on a vesting schedule (or accelerate an existing one) — typically 4-year vesting with a 1-year cliff, with credit for time already served. Two provisions to negotiate:
Acceleration on change of control. Single trigger = automatic acceleration on a sale. Double trigger = acceleration only if the sale is followed by termination without cause or resignation for good reason. Double trigger is market; single trigger is a founder win worth asking for.
Termination without cause. Some acceleration (12 months, or 25–50% of unvested) if the founder is terminated without cause. Absolutely worth negotiating.
You will be required to sign a Proprietary Information and Inventions Agreement assigning all pre-existing and future IP related to the business to the company. Non-compete language varies by state (unenforceable in California, enforceable in most others). Standard.
The no-shop clause prevents the company from soliciting or accepting competing offers for a defined period (typically 30–45 days). It is one of the few binding provisions in the term sheet. Negotiate it down to 30 days maximum, and carve out unsolicited inbound inquiries so you can at least receive (though not respond to) competing bids.
The company reimburses the lead investor's legal fees, typically capped at $30,000–$75,000 for a Series A. Also binding. Negotiate the cap; do not agree to uncapped legal expenses.
Both sides agree to keep the terms confidential (with standard carve-outs for advisors, attorneys, and limited partners). Binding. Standard.
The financing closes only if diligence is completed satisfactorily, definitive documents are signed, and required consents are obtained. This is the exit ramp that lets an investor walk. Move fast and be organized to minimize the risk.
If you take away one thing from this guide, it should be this: the three provisions that will define your relationship with your Series A investors are valuation with option pool treatment, board composition, and liquidation preference structure. Anti-dilution, protective provisions, and founder vesting terms matter and should be negotiated. Everything else is largely standard.
Read the term sheet three times. Model the cap table under three scenarios (as offered, with the option pool moved post-money, and with a 20% dilutive future round). Have your startup attorney (not your general-practice lawyer) redline it. Then, and only then, sign.
This guide is educational and does not constitute legal advice. Consult qualified startup counsel before signing any term sheet.
